$CYRX

CryoPort Inc (CYRX) Shares Down 2.89% on Jan 23

Shares of CryoPort Inc (CYRX) fell 2.89% on January 23, reaching an intraday low of $10.53 before closing at $10.60. Despite the dip, the average one-year price target from analysts suggests a 24.80% upside, indicating an "Outperform" status. However, GuruFocus' estimated GF Value for CYRX suggests a potential downside of 12.98% from the current price.

Original reporting
GuruFocus · GuruFocus News
Published Jan 24, 2026, 12:27 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 24, 2026, 12:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CYRX
Bearish
medium confidence
Mentioned
$CYRX
alphai data visualization · based on GuruFocus
Decision brief

The 30-second read

$CYRXBearishMed
01

Why it matters

While the stock has declined, analyst estimates suggest undervaluation, presenting a potential buying opportunity for patient investors.

02

Market read

The news has moderate relevance for traders focusing on biotech logistics stocks, with potential short-term trading opportunities.

03

What to watch

Potential sector headwinds, upcoming earnings reports, or macroeconomic factors could influence future performance.

Timing: short-term (within 1 month)

Background

CryoPort Inc specializes in temperature-controlled logistics for biotech and pharmaceutical products. The recent share decline may reflect broader sector volatility or company-specific concerns.

Company-level read

Ticker impact

$CYRXBearishMedium confidence
Context

The news pertains directly to CryoPort Inc (CYRX), a biotech logistics company, with a notable price decline and analyst outlook.

Expected impact

Potential short-term rebound due to analyst optimism, but underlying valuation suggests caution. Long-term prospects remain uncertain.

Evidence & confidence

The recent decline indicates short-term selling pressure, but analyst estimates and valuation models suggest the stock may be undervalued, providing opportunities for swing traders and long-term investors. Technical indicators are not provided, limiting precise entry/exit points.

Market effects

The biotech logistics sector may experience volatility; investors should monitor industry trends.

Limited; the news is specific to CYRX and does not indicate regional market shifts.

Low; CryoPort's performance is primarily influenced by sector-specific factors.

Counterpoint

The decline may signal underlying issues not captured by analyst targets, warranting caution before accumulating.

Key entities

  • CryoPort Inc

    A provider of temperature-controlled logistics solutions for the biotech and pharmaceutical industries.

Related articles

$CYRXMed

Cryoport, Inc. (CYRX): Results of Operations and Financial Condition

Cryoport, Inc. (CYRX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622464d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Cryoport Reports Second Quarter 2026 Financial Results · Second quarter revenue grew 8% year-over-year to $49.0 million · Life Sciences Services revenue increased 15% year-over-year · BioStorage/BioServices revenue grew 2

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

$AVAVMedAI 8/10

Bloomberg: US to purchase anti-drone lasers for $400 million

Bloomberg reports the Pentagon will buy laser-based counter-drone systems from AeroVironment Inc. in a deal valued at at least $400 million. The contract is expected to supply the Army with dozens of Locust systems, described as an AI-enabled laser system for tracking and disabling small and medium UAVs. AeroVironment shares rose 8.1% intraday, according to the report.

$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.